Alexandrov LB, Kim J, Haradhvala NJ et al (2020) The repertoire of mutational signatures in human cancer. Nature 578(7793):94–101. https://doi.org/10.1038/s41586-020-1943-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armijo AL, Thongararm P, Fedeles BI et al (2023) Molecular origins of mutational spectra produced by the environmental carcinogen N-nitrosodimethylamine and S(N)1 chemotherapeutic agents. NAR Cancer 5(2):zcad015. https://doi.org/10.1093/narcan/zcad015

Article  PubMed  PubMed Central  Google Scholar 

Ashford AL, Nachmanson D, Wills JW et al (2025) Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis. BioRxiv. https://www.biorxiv.org/content/10.1101/2025.04.29.651210v1. Accessed 15 July 2025

Beal MA, Chen G, Dearfield KL et al (2023) Interpretation of in vitro concentration-response data for risk assessment and regulatory decision-making: report from the 2022 IWGT quantitative analysis expert working group meeting. Environ Mol Mutagen. https://doi.org/10.1002/em.22582

Article  PubMed  PubMed Central  Google Scholar 

Bercu JP, Masuda-Herrera M, Trejo-Martin A et al (2023) Acceptable intakes (AIs) for 11 small-molecule N-nitrosamines (NAs). Regul Toxicol Pharmacol 142:105415. https://doi.org/10.1016/j.yrtph.2023.105415

Article  CAS  PubMed  Google Scholar 

Drabløs F, Feyzi E, Aas PA et al (2004) Alkylation damage in DNA and RNA–repair mechanisms and medical significance. DNA Repair (Amst) 3(11):1389–1407. https://doi.org/10.1016/j.dnarep.2004.05.004

Article  CAS  PubMed  Google Scholar 

EMA (2025) Nitrosamine impurities: guidance for marketing authorisation holders. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/referral-procedures-human-medicines/nitrosamine-impurities/nitrosamine-impurities-guidance-marketing-authorisation-holders. Accessed 15 July 2025

FDA (2018) FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity. https://www.fda.gov/news-events/press-announcements/fda-announces-voluntary-recall-several-medicines-containing-valsartan-following-detection-impurity. Accessed 15 July 2025

FDA (2023) Recommended Acceptable Intake Limits for Nitrosamine Drug Substance Related Impurities (NDSRIs) Guidance for Industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/recommended-acceptable-intake-limits-nitrosamine-drug-substance-related-impurities. Accessed 15 July 2025

Florian J, Matta MK, DePalma R et al (2021) Effect of oral ranitidine on urinary excretion of N-nitrosodimethylamine (NDMA): a randomized clinical trial. JAMA 326(3):240–249. https://doi.org/10.1001/jama.2021.9199

Article  CAS  PubMed  Google Scholar 

Gushgari AJ, Halden RU (2018) Critical review of major sources of human exposure to N-nitrosamines. Chemosphere 210:1124–1136. https://doi.org/10.1016/j.chemosphere.2018.07.098

Article  CAS  PubMed  Google Scholar 

Heflich RH, Johnson GE, Zeller A et al (2020) Mutation as a toxicological endpoint for regulatory decision-making. Environ Mol Mutagen 61(1):34–41. https://doi.org/10.1002/em.22338

Article  CAS  PubMed  Google Scholar 

Herrmann SS, Duedahl-Olesen L, Christensen T, Olesen PT, Granby K (2015) Dietary exposure to volatile and non-volatile N-nitrosamines from processed meat products in Denmark. Food Chem Toxicol 80:137–143. https://doi.org/10.1016/j.fct.2015.03.008

Article  CAS  PubMed  Google Scholar 

Hrudey SE, Bull RJ, Cotruvo JA, Paoli G, Wilson M (2013) Drinking water as a proportion of total human exposure to volatile N-nitrosamines. Risk Anal 33(12):2179–2208. https://doi.org/10.1111/risa.12070

Article  PubMed  Google Scholar 

ICH M7 Sub-group (2025) Addendum to ICH M7 on Risk Assessment and Control of N-Nitrosamine Impurities. https://database.ich.org/sites/default/files/ICH_M7SubGroup_Final_Concept_Paper_2024_0424.pdf. Accessed 15 July 2025

ICH (2023) Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R2). https://database.ich.org/sites/default/files/ICH_M7%28R2%29_Guideline_Step4_2023_0216_0.pdf. Accessed 15 July 2025

ICH (2024) Impurities: guideline for residual solvents Q3C(R9). https://database.ich.org/sites/default/files/ICH_Q3C%28R9%29_Guideline_MinorRevision_2024_2024_Approved.pdf. Accessed 15 July 2025

Jenkins GJ, Doak SH, Johnson GE, Quick E, Waters EM, Parry JM (2005) Do dose–response thresholds exist for genotoxic alkylating agents? Mutagenesis 20(6):389–398. https://doi.org/10.1093/mutage/gei054

Article  CAS  PubMed  Google Scholar 

Johnson GE, Dobo K, Gollapudi B et al (2021) Permitted daily exposure limits for noteworthy N-nitrosamines. Environ Mol Mutagen 62(5):293–305. https://doi.org/10.1002/em.22446

Article  CAS  PubMed  Google Scholar 

Kondo N, Takahashi A, Ono K, Ohnishi T (2010) DNA damage induced by alkylating agents and repair pathways. J Nucleic Acids 2010:543531. https://doi.org/10.4061/2010/543531

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kucab JE, Zou X, Morganella S et al (2019) A Compendium of Mutational Signatures of Environmental Agents. Cell 177(4):821–836 e16. https://doi.org/10.1016/j.cell.2019.03.001

Lee HS (2024) Dietary exposure assessment for volatile N-nitrosamines from food and beverages for the U.S. population. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. https://doi.org/10.1080/19440049.2024.2398704

Article  PubMed  Google Scholar 

Li Y, Hecht SS (2022) Metabolic activation and DNA interactions of carcinogenic N-nitrosamines to which humans are commonly exposed. Int J Mol Sci. https://doi.org/10.3390/ijms23094559

Article  PubMed  PubMed Central  Google Scholar 

Lynch AM, Howe J, Hildebrand D et al (2024) N-nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulations. Mutagenesis 39(2):96–118. https://doi.org/10.1093/mutage/geae001

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacGregor JT, Frötschl R, White PA et al (2015) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). Mutat Res Genet Toxicol Environ Mutagen 783:55–65. https://doi.org/10.1016/j.mrgentox.2014.09.011

Article  CAS  PubMed  Google Scholar 

Marchetti F, Cardoso R, Chen CL et al (2023) Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing. Nat Rev Drug Discov 22(3):165–166. https://doi.org/10.1038/d41573-023-00014-y

Article  CAS  PubMed  Google Scholar 

Nohmi T, Masumura K (2004) Gpt delta transgenic mouse: a novel approach for molecular dissection of deletion mutations in vivo. Adv Biophys 38:97–121

Article  CAS  PubMed  Google Scholar 

Parsons BL, Beal MA, Dearfield KL et al (2024) Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT). Environ Mol Mutagen. https://doi.org/10.1002/em.22599

Article  PubMed  Google Scholar 

Paustenbach DJ, Brown SE, Heywood JJ, Donnell MT, Eaton DL (2024) Risk characterization of N-nitrosodimethylamine in pharmaceuticals. Food Chem Toxicol 186:114498. https://doi.org/10.1016/j.fct.2024.114498

Article  CAS  PubMed  Google Scholar 

Pegg AE (2011) Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools. Chem Res Toxicol 24(5):618–639. https://doi.org/10.1021/tx200031q

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peterson LA, Stanfill SB, Hecht SS (2024) An update on the formation in tobacco, toxicity and carcinogenicity of N’-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 45(5):275–287. https://doi.org/10.1093/carcin/bgae018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peto R, Gray R, Brantom P, Grasso P (1991) Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res 51(23 Pt 2):6452–6469

CAS  PubMed  Google Scholar 

Salk JJ, Kennedy SR (2020) Next-generation genotoxicology: using modern sequencing technologies to assess somatic mutagenesis and cancer risk. Environ Mol Mutagen 61(1):135–151. https://doi.org/10.1002/em.22342

Article  CAS  PubMed  Google Scholar 

Schrenk D, Bignami M, Bodin L et al (2023) Risk assessment of N-nitrosamines in food. EFSA J 21(3):e07884. https://doi.org/10.2903/j.efsa.2023.7884